Evidence map›Paper›PMID 42309026›Full record

ArticleBreast (Edinburgh, Scotland)2026

Factors associated with local breast cancer recurrence after mastectomy in the Netherlands: a retrospective nationwide cohort study.

T D A Stindt, M C van Maaren, B V Offersen, S Siesling, D J P van Uden, P M P Poortmans, L J Boersma, O Kaidar-Person

Abstract read
In one paragraph

Article in Breast (Edinburgh, Scotland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

T D A StindtDepartment of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, Enschede, 7500 AE, the Netherlands.
M C van MaarenDepartment of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, Enschede, 7500 AE, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. Electronic address: m.c.vanmaaren@utwente.nl.
B V OffersenDepartment of Experimental Clinical Oncology, Aarhus University Hospital, Denmark.
S SieslingDepartment of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, Enschede, 7500 AE, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
D J P van UdenDepartment of Surgery, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
P M P PoortmansDepartment of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium.
L J BoersmaDepartment of Radiation Oncology (Maastro), GROW- Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
O Kaidar-PersonDepartment of Radiation Oncology (Maastro), GROW- Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands; Gray School of Medical Sciences, Faculty of Medical and Health Science, Aviv University, Tel-Aviv, Israel; Breast Radiation Unit, Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite presumed complete removal of glandular breast tissue, breast cancer (BC) patients can experience local recurrence (LR) after mastectomy. Most trials report recurrences as locoregional recurrence, potentially obscuring risk factors for LR. In this study, incidence of and risk factors for isolated LR after mastectomy were analysed.

methodsWomen diagnosed with primary unilateral nonmetastatic BC treated with mastectomy between 2012 and 2016 were selected from the Netherlands Cancer Registry. LR incidence was assessed within guideline-based indication groups. Multivariable Cox regression models were constructed for patients with and without primary systemic therapy (PST).

resultsIn total, 17,082 non-PST and 5033 PST patients were included, of whom 345 (2%) and 80 (1.6%) had LR after a median follow-up of 7.8 and 6.7 years, respectively. LR rates were low but varied between indication groups. In the non-PST group, screening detection, low grade, targeted therapy while HER2-positive, radiation therapy (RT), and adjuvant chemotherapy were associated with lower LR risk. Younger age, inner-quadrant location, higher tumour and nodal stage, immediate reconstruction, and omission of endocrine therapy were associated with higher LR risk. In the PST group, pathologic complete response, HER2-positivity, and RT were associated with lower LR risks, while higher clinical T stage, presence of ductal carcinoma in situ, and no endocrine therapy while hormone-receptor positive were associated with higher LR risk.

conclusionWe identified several factors associated with LR rates after mastectomy. Despite the observational character of our study, these factors could be considered in future treatment decision-making.

Indexed as

Breast NeoplasmsMastectomyNeoplasm Recurrence, LocalAdultAgedChemotherapy, AdjuvantFemaleHumansIncidenceMiddle AgedNetherlandsRadiotherapy, AdjuvantRegistriesRetrospective StudiesRisk FactorsBreast cancerLocal recurrenceMastectomyPrimary systemic therapyRadiation therapyRisk factors

Identifiers

PMID42309026
PMCPMC13284424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.